Abstract:PurposeObstructive sleep apnea (OSA) is implicated in the pathogenesis of cardiovascular diseases such as coronary artery disease, rhythm disturbances, heart failure, and stroke. Increased sympathetic activity and decreased parasympathetic activity have been implicated as the causes for the above. Effective treatment with positive airway pressure (PAP) significantly reduces the cardiovascular outcomes associated with OSA. Treatment of OSA with positive airway pressure (PAP) therapy has resulted in improved risk of cardiovascular morbidity, possibly by changing the sympathetic and parasympathetic drive. Although long-term effects of this therapy have been observed in the previous studies, we have explored the split night effect of PAP therapy on the sympathetic and parasympathetic activities in our study.MethodsFourteen patients with severe OSA who had split night study were enrolled. All were well controlled with continuous positive airway pressure (CPAP) therapy. 10 min epoch of electrocardiogram (ECG) was selected in the diagnostic phase as well as during the CPAP usage in stage 2 and 3 sleep. Low-frequency (LF), high-frequency (HF) power and LF–HF ratios were calculated and compared for sleep stages 2 and 3 separately in the diagnostic and titration phases.ResultsHigher LF–HF ratio was seen in the diagnostic phase which significantly reduced after CPAP therapy for both sleep stages 2 and 3 (p < 0.05).ConclusionA significant decrease in LF–HF ratio was seen in the patients after the use of CPAP for more than 4 h. This could have great impact on the cardiovascular system.

Impact of CPAP on LF Power, HF Power and LF–HF Ratio in Patients with Severe OSA During Split Night Study